EVIO

EVIO Receivables

The Accounts Receivable of EVIO (EVIO) as of Oct 25, 2026 is 422,000.00 USD. In the previous year, Accounts Receivable was 129,000.00 USD — a change of 227.13% (higher).

Receivables

422,000.00USD

YoY

227.13%

Last updated:

Accounts Receivable of EVIO is 2021 422,000.00 USD. Accounts Receivable of EVIO was 2020 129,000.00 USD. It decreases by 227.13% higher compared to the previous year.

The EVIO Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2015
11,600.00 USD
Jan 1, 2016
9,500.00 USD
Jan 1, 2017
229,600.00 USD
Jan 1, 2018
234,200.00 USD
Jan 1, 2019
133,000.00 USD
Jan 1, 2020
129,000.00 USD
Jan 1, 2021
422,000.00 USD
The EVIO Receivables history
YEARReceivablesYoY
422,000.00USD+227.13%
129,000.00USD-3.01%
133,000.00USD-43.21%
234,200.00USD+2.00%
229,600.00USD+2,316.84%
9,500.00USD-18.10%
11,600.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EVIO Stock analysis

What does EVIO do? EVIO, Inc. generates revenue through analytical testing services for cannabis and hemp products, targeting agricultural and pharmaceutical industries. The company operates subsidiaries including Smith Scientific Industries, LLC, Greenhaus Analytical Labs, LLC, and Viridis Analytics, LLC, which provide testing to verify regulatory compliance for product sales. Residential and commercial construction services form another revenue stream, while research and development and consulting services cater to cannabis and hemp industry participants. Subsidiaries such as EVIO Labs OR, Inc., C3 Labs, LLC, and EVIO Labs Humboldt, LLC further support the company's service offerings. The primary customers for EVIO's testing services are businesses within the cannabis and hemp sectors requiring regulatory verification. Construction services are sold to residential and commercial clients, while R&D and consulting services target industry participants seeking expertise. Subsidiaries like Keystone Labs, Inc. contribute to the analytical testing segment, ensuring compliance with market requirements. EVIO's revenue model relies on multiple service lines across different industry segments without relying on external partnerships or third-party platforms. EVIO's service portfolio includes analytical testing, construction, and consulting, with all operations managed through its subsidiaries. The company's focus on regulatory compliance for cannabis and hemp products drives demand for its testing services. Construction services provide additional revenue, while R&D and consulting support industry growth. Subsidiaries such as Smith Scientific Industries, LLC and Greenhaus Analytical Labs, LLC operate under the EVIO brand to deliver specialized services to clients in the agricultural and pharmaceutical sectors. EVIO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EVIO stock

Accounts Receivable of EVIO is 422,000.00 USD in 2021.

Accounts Receivable of EVIO changed from 129,000.00 USD to 422,000.00 USD, representing a 227.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable EVIO since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's EVIO historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — EVIO

All Key Metrics — EVIO